Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

CD4+ skin cells may be precursors to basal cell carcinoma.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

Acne inversa is an epithelial-driven disease where inflammation is caused by cyst rupture, and treatments should focus on preventing tendril growth for better results.

Improving artificial vascular grafts requires better materials and surface designs to reduce blood clotting and support blood vessel cell growth.

The patient with total hair loss did not regrow hair despite treatment, indicating a poor outlook for this type of hair loss.

HO-1 helps skin health and healing but can worsen melanoma; it's a potential treatment target for skin diseases.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

Semecarpus anacardium leaf extract fights breast cancer and extends survival in mice.

Plasma-activated liquid can kill harmful cells, speed up wound healing, and potentially treat cancer without damaging healthy cells.

The material combining eggshell protein and scaffold helps wounds heal faster and regenerates tissue effectively.

New technologies show promise in healing wounds, treating cancer, autoimmune diseases, and genetic disorders.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Scientists found a new, less invasive way to get stem cells from horse hair for veterinary medicine.

Hair follicle stem cells and skin cells show promise for hair and skin therapies but need more research for clinical use.

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Tiny particles called extracellular vesicles show promise for treating skin conditions and promoting hair growth.

Cell-based therapies show promise for treating Limbal Stem Cell Deficiency but need more research.

Exosomes could potentially enhance tissue repair and regeneration with lower rejection risk and easier production than live cell therapies.

Bacterial cellulose is a promising material for biomedical uses but needs improvements in antimicrobial properties and degradation rate.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Cannabinoids may help treat various skin conditions.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

The workshop discussed the role of a protein called calreticulin in health and disease, its potential as a treatment target, and its possible use as a disease marker.

Trichohyalin-like proteins are essential for the development of skin structures like hair, nails, and feathers.

Mutations in the NR3C1 gene cause a rare condition that affects hormone signaling and can lead to various symptoms, with dexamethasone as a treatment option.